Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers January 20, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - January 20, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 16 of 16     Go To Page:

1/20/17 - Ala-Septic is a patented, topical OTC medication that has major indications for acne, psoriasis, dermatitis, podiatry, and osteoarthritis. The proprietary product is 98% natural
Ala-Septic Pharmaceutical Research, LLC was established in March 2009. The strategy of Ala-Septic Pharmaceutical Research, LLC has been to develop topical treatments for Pre-Melanoma Skin Cancer lesions and Melanoma Skin Cancer lesions. Ala-Septic is currently manufactured by Pure Source Labs, an FDA ap.
1/20/17 - Lobster blood could be the next best thing to help treat warts, shingles [Bangor Daily News, Maine]
Lobster industry researchers in Maine say they've determined that uncooked lobster hemolymph, or blood, has medicinal properties that can be used to treat viruses that cause warts and shingles. The product, developed by Lobster Unlimited LLC is patented but not yet available in stores. Cathy Billings, an official with Lobster Unlimited, said in a p
1/19/17 - Abbott Said to Cut 200 Employees
Abbott replied on January 18 " China is an important market for the company that is confident in the Chinese market and will continue to invest and develop business. Roche, Sanofi, UCB, GSK, Squibb, Boehringer Ingelheim and other well-known pharmaceutical companies are said to cut employees in China. UCB announced it will sell and outsource Broncho
1/19/17 - Kasten, Inc. Provides Shareholder Update on Status of Projects
SILVER SPRINGS, NV/ ACCESSWIRE/ January 19, 2017/ Kasten, Inc. updated its shareholders today on the status of its pending projects. Per the agreement, the name of the JV shall be KD Joint Venture, Inc. and the purpose shall be to develop, fund, and market Site Specific Penetration Technology biopharmaceutical products. This is expected to dramatic
1/19/17 - SeeThruEquity Issues Update on PixarBio Corporation (OTCQX: PXRB)
NEW YORK, NY/ ACCESSWIRE/ December 19, 2016/ SeeThruEquity, the leading independent equity research firm focused on smallcap and microcap public companies, today announced it has issued an update note on PixarBio Corporation. Based in Cambridge, MA, PixarBio Corporation is a specialty pharmaceutical company focused on pre-clinical and clinical comm
1/18/17 - CORRECTING and REPLACING Ipsen Biopharmaceuticals, Inc. Announces Poster Presentations at ASCO 2017 Gastrointestinal Cancers Symposium
IPSEN BIOPHARMACEUTICALS, INC. ANNOUNCES POSTER PRESENTATIONS AT ASCO 2017 GASTROINTESTINAL CANCERS SYMPOSIUM. Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that four abstracts were selected for poster presentation during the annual ASCO Gastrointestinal Cancers Symposium being held in San Francisco, Calif., January 19 2
1/18/17 - FDA Grants Genentech's Cancer Immunotherapy Tecentriq (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
Release date- 17012017- South San Francisco, CA- Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application and granted Priority Review for TECENTRIQ for the treatment of people with locally advanced or metastatic urothelial carcinoma who a
1/18/17 - Ipsen Biopharmaceuticals, Inc. Announces Poster Presentations at ASCO 2017 Gastrointestinal Cancers Symposium
Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that four abstracts were selected for poster presentation during the annual ASCO Gastrointestinal Cancers Symposium being held in San Francisco, Calif., January 19 21, 2017.. These studies collectively demonstrate Ipsen s steadfast focus on enhancing our understanding o
1/18/17 - Natural Human Growth Hormone (HGH) Supplements: HGH.com Shares Top 10 Benefits of HGH Releasers
Human growth hormone has been credited with a variety of positive effects on health and wellness; but since injectable HGH can only legally be prescribed for a limited range of health conditions,* many consumers have turned to natural HGH supplements. HGH.com, an established industry leader that manufactures a range of health and bodybuilding sup
1/17/17 - $200+ Billion Active Pharmaceutical Ingredients/API Market 2016-2021: Market is Expected to Reach USD 213.97 Billion by 2021 from USD 157.95 Billion in 2016 - Research and Markets
Research and Markets has announced the addition of the "Active Pharmaceutical Ingredients/API Market by Type, Manufacturer, Synthesis, Product Drug, Therapy- Global Forecast to 2021" report to their offering. The global active pharmaceutical ingredients market is expected to reach USD 213.97 Billion by 2021 from USD 157.95 Billion in 2016, growing
1/17/17 - Eosera? Introduces Earwax MD? To Clear Ears & Change Lives
EOSERA?, Inc., a Dallas- based biotechnology innovator founded by two veterans of the pharmaceutical industry, today announced the introduction of Earwax MD? the ideal solution for those who dread the time, worry, and expense of a doctor's visit to clear their ears of burdensome earwax impaction. The new product finally offers relief for a
1/16/17 - Active Pharmaceutical Ingredients/API Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug (OTC, Rx), Therapy (Diabetes, Oncology, CNS, CVD) - Global Forecast to 2021
The active pharmaceutical ingredients market in terms of value is expected to reach USD 213.97 billion by 2021 from USD 157.95 billion in 2016, growing at a CAGR of 6.3% from 2016 to 2021. For instance, in 2008, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, launched the Jan Aushadhi Scheme for prov
1/16/17 - FDA Provides Positive and Encouraging Feedback for 22nd Century's Very Low Nicotine MRTPA Filings
On December 31, 2015, the Company's wholly owned subsidiary, Goodrich Tobacco Company, submitted MRTPAs and PMTAs to the FDA seeking a reduced exposure order for 22nd Century's "BRAND A" Very Low Nicotine cigarettes. More specifically, the Company requested in its MRTPAs permission from the FDA to be able to state, as truthful and accurate in BRAND
1/16/17 - Pharmaceutical Excipients Global Market - Forecast to 2022
Pharmaceutical excipients are inactive substances in the drug which helps in modulating solubility, bioavailability and stability of active substances for formulating final drug dosage forms. The excipients form the major part of any medicinal product and proportion of it when compared to Active Pharmaceutical Agent exceeds two to three fold in a
1/16/17 - The overuse of antibiotics in food animals [Citizen, The (Tanzania)]
Recently, I read an article published in Your Health, by Dr Mpokigwa Kiputa, entitled; Powercef: Medicine widely used and abused in TZ. This prompted me to write this article and put the issue of antibiotic resistance in perceptive as an expert on infectious diseases. Antibiotic resistance is endangering the achievement of the Sustainable Dev
1/16/17 - The Therapeuticsmd Inc (Txmd) Rating Decreased to Sell at the Zacks Investment Research [Egypt Independent]
Zacks Investment Research cut shares of TherapeuticsMD Inc from a hold rating to a sell rating in a report published on Wednesday. According to Zacks, TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women.
Articles(s): 1 - 16 of 16     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415